Quo Vadis Trastuzumab?: Navigating Cardiac Safety Risk Estimates With Complex Cancer Treatments.
Quo Vadis Trastuzumab?: Navigating Cardiac Safety Risk Estimates With Complex Cancer Treatments.
- 2019
English
2213-1779
10.1016/j.jchf.2018.10.020 [doi] S2213-1779(18)30831-X [pii]
*Breast Neoplasms
*Heart Failure
Cardiotoxicity
Chemotherapy, Adjuvant
Heart
Humans
Trastuzumab
MedStar Heart & Vascular Institutena
Comment
Editorial
English
2213-1779
10.1016/j.jchf.2018.10.020 [doi] S2213-1779(18)30831-X [pii]
*Breast Neoplasms
*Heart Failure
Cardiotoxicity
Chemotherapy, Adjuvant
Heart
Humans
Trastuzumab
MedStar Heart & Vascular Institutena
Comment
Editorial